E
LSL Pharma Group Inc. LSL.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024
Revenue -4.03% -0.81%
Total Other Revenue -- --
Total Revenue -4.03% -0.81%
Cost of Revenue 6.37% -13.29%
Gross Profit -22.01% 32.06%
SG&A Expenses -35.73% 70.68%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses -9.17% 7.16%
Operating Income 160.79% -178.16%
Income Before Tax 24.95% -81.56%
Income Tax Expenses -- --
Earnings from Continuing Operations 24.95% -81.56%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income 24.95% -81.56%
EBIT 160.79% -178.16%
EBITDA 116.36% -60.81%
EPS Basic 30.56% -44.00%
Normalized Basic EPS 33.33% -60.00%
EPS Diluted 30.56% -44.00%
Normalized Diluted EPS 33.33% -60.00%
Average Basic Shares Outstanding 8.80% 25.06%
Average Diluted Shares Outstanding 8.86% 25.20%
Dividend Per Share -- --
Payout Ratio -- --
Weiss Ratings